Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2020-04-01 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
2020年第一季度可转换公司债券转股情况公告
Capital/Financing Update Classification · 95% confidence The document is a quarterly announcement regarding the convertible bonds (可转换公司债券) and the related share conversion activity for the first quarter of 2020. It details the bond issuance, conversion prices, adjustments, and the resulting changes in shareholding structure. The document is titled as a "2020年第一季度可转换公司债券转股情况公告" which translates to "2020 First Quarter Convertible Bond Conversion Announcement." It contains specific data on bond conversion and share changes but does not present comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR). Instead, it is an announcement of bond conversion and shareholding changes, which aligns with a Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes. The document length is 2387 characters, relatively short, and it is a direct announcement, not a report publication notice or certification. Therefore, the best fitting category is Capital/Financing Update (CAP).
2020-04-01 Chinese
关于举行2019年度网上业绩说明会的通知
Investor Presentation Classification · 95% confidence The document is a notice about holding an online performance explanation meeting (业绩说明会) for the 2019 annual report. It references the 2019 annual report already disclosed on March 27, 2020, and invites investors to participate in the online meeting on April 3, 2020. The document is short (627 characters) and serves as an announcement for an event related to the annual report, not the report itself. Therefore, it fits the category of Investor Presentation (IP) since it is a detailed presentation event focusing on financials and company performance, rather than the full annual report or a simple announcement of report publication (RPA).
2020-03-31 Chinese
2019年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2019 年年度报告摘要" which translates to "2019 Annual Report Summary". It contains detailed financial data for the year 2019, including revenue, net profit, earnings per share, and other financial indicators. It also discusses company business operations, industry context, accounting policy changes, and shareholder information. The length of the document (9866 characters) and the depth of financial and operational information indicate it is a substantive financial report rather than a brief announcement or a presentation. The document is clearly a summary of the full annual report, providing comprehensive financial and business information for the fiscal year 2019. Therefore, it fits the definition of an Annual Report (10-K). FY 2019
2020-03-26 Chinese
2019年年度审计报告
Regulatory Filings
2020-03-26 Chinese
内部控制鉴证报告
Regulatory Filings
2020-03-26 Chinese
募集资金存放与实际使用情况审核报告
Regulatory Filings
2020-03-26 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.